# User Performance Evaluation of Contour® Next One, Accu-Chek® Aviva Connect, FreeStyle Freedom Lite, OneTouch® Verio and GlucoMen® Areo Blood Glucose Monitoring Systems Following ISO 15197:2013

> **NCT03033849** · NA · COMPLETED · sponsor: **Institut für Diabetes-Technologie Forschungs- und Entwicklungsgesellschaft mbH an der Universität Ulm** · enrollment: 189 (actual)

## Conditions studied

- Diabetes Mellitus

## Interventions

- **DEVICE:** Blood glucose monitoring system for self-testing Contour® Next One
- **DEVICE:** Blood glucose monitoring system for self-testing Accu-Chek® Aviva Connect
- **DEVICE:** Blood glucose monitoring system for self-testing FreeStyle Freedom Lite
- **DEVICE:** Blood glucose monitoring system for self-testing OneTouch® Verio
- **DEVICE:** Blood glucose monitoring system for self-testing GlucoMen® areo

## Key facts

- **NCT ID:** NCT03033849
- **Lead sponsor:** Institut für Diabetes-Technologie Forschungs- und Entwicklungsgesellschaft mbH an der Universität Ulm
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-01
- **Primary completion:** 2017-03
- **Final completion:** 2017-03
- **Target enrollment:** 189 (ACTUAL)
- **Last updated:** 2017-09-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03033849

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03033849, "User Performance Evaluation of Contour® Next One, Accu-Chek® Aviva Connect, FreeStyle Freedom Lite, OneTouch® Verio and GlucoMen® Areo Blood Glucose Monitoring Systems Following ISO 15197:2013". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03033849. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*